Key Takeaways
- Swissmedic has updated its guidance on decentralized clinical trials (DCTs), and made it easier for companies to compare Swiss requirements with those of EU member states.
Switzerland’s medicines regulator, Swissmedic, has overhauled its position paper on decentralized clinical trials (DCTs) to align with guidance issued by...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?